This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Print page

Healthcare & Life Sciences

The Healthcare & Life Sciences (HLS) sector is facing a wide range of major challenges driven by the need to protect current earnings, transform business models (to do more with less) and grow new businesses in related areas. Ongoing challenges include: healthcare compliance, product withdrawals, fraud and counterfeit, espionage and security and the need to demonstrate economic value. All these remain relevant and must be addressed to support and enable safe transformation and growth. Strengthening risk management capabilities and building organisation resilience support success and are essential during change.

Risk in Healthcare & Life Sciences

Whether using analytics to predict drug safety issues or creating global commercial compliance frameworks, Deloitte’s David Hodgson highlights some of the approaches being adopted by some of our Healthcare & Life Sciences clients.

Our Services

Data Analytics

Regulatory & Compliance

Risk, Control & Audit

Security & Resilience

 

Contact

  • David Hodgson
    Lead partner
    +44 20 7007 9934

Related insights

Are advanced analytics good medicine?

Are advanced analytics good medicine?
The latest Deloitte perspective published in the Wall Street journal.

Useful links

  • Research & Publications
  • In the press
  • Careers
  • Submit a request for proposal
  • Contact us

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options
Follow:

Get in touch

More on Deloitte